Progenity to Present at Three Key Investor Conferences
SAN DIEGO--(BUSINESS WIRE)--Feb 25, 2019--Progenity, Inc., a privately held biotechnology company developing precision medicine solutions across genomic/epigenomic, proteomic, and…
SAN DIEGO--(BUSINESS WIRE)--Feb 25, 2019--Progenity, Inc., a privately held biotechnology company developing precision medicine solutions across genomic/epigenomic, proteomic, and…